AUTHORS
Nandini Rajaram Siva, MD, Mark David Orland, MD, PhD2, Carlos Bravo-Perez, MD3, Luca Guarnera, MD4, Zachary Brady, BS5, Kartik Lakhotiya, MS6, Atsushi Marumo, MD7, Carmelo Gurnari, MD,PhD8, Serhan Unlu, MD9, Valeria Visconte, PhD10, Jaroslaw P. Maciejewski, MD, PhD, FACP11
AFFILIATIONS
1 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
2 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
3 Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
4 University of Rome Tor Vergata, Rome, Italy
5 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
6 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
7 Nippon Medical School, Tokyo, Japan, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
8 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States, University Hospital “San Giovanni di Dio e Ruggi d'Aragona”, Ercolano, Italy
9 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
10 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
11 Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
ABSTRACT
T-cell large granular lymphocytic leukemia (T-LGLL) is traditionally regarded as a “hyperimmune” clonal lymphoproliferation of cytotoxic T lymphocytes (CTLs), frequently harboring activating STAT3 mutations. This paradigm has been recently challenged by evidence that T-LGLL often arises in the setting of an underlying immune deficiency rather than immune excess. Indeed, because of the enrichment of germline inborn errors of immunity (IEI) in LGLL (Bravo-Perez et al., JCI 2025), one could theorize that clonal T-cell expansion represents a maladaptive compensatory response to chronic immune dysfunction. Because telomere attrition limits lymphocyte replicative capacity and immune reserve, we hypothesized that telomere shortening in the lymphocyte compartment contributes to the characteristic failure to develop lymphocytosis in T-LGLL and creates selective pressure for compensatory clonal expansions. Such attrition has also been found in inherited telomeropathies, with the resultant lymphopenia also often found in the context of T-LGLL.
Lymphocyte telomere length (TL) was quantified by standard telomere flow-FISH. Lymphocyte TL was correlated with absolute lymphocyte count (ALC), while granulocyte TL served as an internal non-clonal reference.T-LGLL is often characterized by failure to develop lymphocytosis despite clonal cytotoxic T-cell expansion. In this study, among 241 patients, 169 (66%) had low or normal absolute lymphocyte counts, whereas only 83 (34%) exhibited lymphocytosis. Immune deficiency manifestations were identified in 186 of 241 (77%), including hypogammaglobulinemia in 64 of 201 (32%), supporting immune deficiency as a defining biological feature of T-LGLL.
Lymphocyte TL demonstrated a strong positive correlation with ALC (r=0.91, n=12), with shorter TL associated with progressively lower lymphocyte counts. This finding is opposite to that anticipated according to a proliferation-driven model, in which increasing clonal expansion would be expected to accompany greater telomere erosion and higher lymphocyte counts. Instead, our results suggest that telomere-limited lymphoid compartments possess diminished capacity to sustain normal lymphocyte numbers and that clonal expansion may partially compensate for this exhausted immune state.
Flow-FISH demonstrated substantial interpatient heterogeneity, with most T-LGLL lymphocyte TL falling between the 10th and 50th age-adjusted percentiles. By contrast, the 5 patients with inherited telomere biology disorders or acquired bone marrow failure measured on the same platform fell below the 1st percentile, indicating moderate rather than telomeropathy-range attrition in T-LGLL. qPCR performed on bulk DNA did not show this relationship, whereas lineage-specific flow-FISH recovered the association between lymphocyte telomere attrition and lymphocyte counts. As expected, concordance between qPCR and flow-FISH was moderate (lymphocyte R² = 0.48; granulocyte R² = 0.60). Lack of changes in granulocyte TL despite lymphocyte-specific shortening supported replicative exhaustion rather than generalized constitutional telomere dysfunction. We have also identified 15 patients with T-LGLL and unusually early presentation in whom heterozygous, high-confidence deleterious variants across 13 IEI-linked genes were found; these carriers were diagnosed earlier than noncarriers (median 55 vs 64 years,P=0.01), had lower lymphocyte counts with higher rates of frank lymphocytopenia (27% vs 3%, P=0.006), and less frequently harbored somatic STAT3 mutations (27% vs 49%).
Our results support a possible pathophysiologic scenario in which T-LGLL develops within an exhausted immune compartment rather than as a primary lymphoproliferative disorder. Integrating our genomic observations with compartment-specific telomere measurements, we propose that lymphocyte telomere attrition arising through aging, chronic antigenic stimulation, inherited immune defects, and/or occult abnormalities of telomere maintenance, altogether, create an immune environment with diminished lymphocyte reserve that favors maladaptive compensatory clonal expansion. Rather than representing the initiating event, clonal T-cell expansion may preserve lymphocyte persistence within a telomere-limited compartment. This framework unifies immune deficiency and telomere biology in T-LGLL, and identifies lymphocyte TL as a candidate biomarker for future telomerase-directed therapeutic investigation extended to this disease
DISCLOSURES
Nandini Rajaram Siva, MD: No relevant conflicts of interest to declare.